Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1 in the footer, which does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and a new 'Revision: v3.4.0' label, and removed older QC/FEAR Act-related labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedThe only visible change is the revision label updated from Revision: v3.3.3 to Revision: v3.3.4. No study content, data, or user-facing information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Ohio as the study site. Removed the Ohio Locations and HHS Vulnerability Disclosure items; page revision updated to v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed.SummaryDifference0.1%

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.